Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ)verified

XVIPF

Price:

$18.6

Market Cap:

$5.85B

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP....[Read more]

Industry

Medical - Devices

IPO Date

2014-07-21

Stock Exchange

OTC

Ticker

XVIPF

The ROE as of December 2025 (TTM) for Xvivo Perfusion AB (publ) (XVIPF) is 1.42%

According to Xvivo Perfusion AB (publ)’s latest financial reports and current stock price. The company's current ROE is 1.42%. This represents a change of 311.90% compared to the average of 0.34% of the last 4 quarters.

Xvivo Perfusion AB (publ) (XVIPF) Historical ROE (quarterly & annually)

How has XVIPF ROE performed in the past?

The mean historical ROE of Xvivo Perfusion AB (publ) over the last ten years is 1.80%. The current 1.42% ROE has changed -21.15% with respect to the historical average. Over the past ten years (40 quarters), XVIPF's ROE was at its highest in in the September 2024 quarter at 4.12%. The ROE was at its lowest in in the June 2020 quarter at -2.81%.

Quarterly (TTM)
Annual

Average

1.80%

Median

1.26%

Minimum

-4.34%

Maximum

7.98%

Xvivo Perfusion AB (publ) (XVIPF) ROE by Quarter and Year

Discovering the peaks and valleys of Xvivo Perfusion AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 266.38%

Maximum Annual ROE = 7.98%

Minimum Annual Increase = -607.11%

Minimum Annual ROE = -4.34%

Quarterly (TTM)
Annual
YearROEChange
20247.98%69.11%
20234.72%266.38%
20221.29%103.17%
20210.63%-114.62%
2020-4.34%-607.11%
20190.86%-63.56%
20182.35%89.08%
20171.24%161.66%
20160.47%-82.91%
20152.78%30.81%

Xvivo Perfusion AB (publ) (XVIPF) Average ROE

How has XVIPF ROE performed in the past?

The current ROE of Xvivo Perfusion AB (publ) (XVIPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.66%

5-year avg

2.06%

10-year avg

1.80%

Xvivo Perfusion AB (publ) (XVIPF) ROE vs. Peers

How is XVIPF’s ROE compared to its peers?

Xvivo Perfusion AB (publ)’s ROE is less than PolyNovo Limited (16.65%), greater than 4DMedical Limited (-39.68%), less than CellaVision AB (publ) (18.19%), less than Lattice Biologics Ltd. (23.33%), less than Swedencare AB (publ) (0.87%), less than Viva Biotech Holdings (4.48%), less than Avon Technologies Plc (1.84%), less than Beijing Tong Ren Tang Chinese Medicine Company Limited (12.72%), greater than Nxera Pharma Co., Ltd. (-4.86%), less than Avisa Diagnostics Inc. (408.59%),

Build a custom stock screener for Xvivo Perfusion AB (publ) (XVIPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xvivo Perfusion AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xvivo Perfusion AB (publ) (XVIPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xvivo Perfusion AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Xvivo Perfusion AB (publ)'s ROE?

How is the ROE calculated for Xvivo Perfusion AB (publ) (XVIPF)?

What is the highest ROE for Xvivo Perfusion AB (publ) (XVIPF)?

What is the 3-year average ROE for Xvivo Perfusion AB (publ) (XVIPF)?

What is the 5-year average ROE for Xvivo Perfusion AB (publ) (XVIPF)?

How does the current ROE for Xvivo Perfusion AB (publ) (XVIPF) compare to its historical average?